NEW YORK, June 15, 2024 /PRNewswire/ — Pomerantz LLP announces that a class action lawsuit has been filed against Enphase Energy, Inc. (“Enphase” or the “Company”) (NASDAQ: ENPH). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or…
Month: June 2024
NEW YORK, June 15, 2024 /PRNewswire/ — Pomerantz LLP announces that a class action lawsuit has been filed against Direct Digital Holdings, Inc. (“Direct Digital” or the “Company”) (NASDAQ: DRCT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or…
NEW YORK, June 15, 2024 /PRNewswire/ — Pomerantz LLP announces that a class action lawsuit has been filed against Cambium Networks Corporation (“Cambium” or the “Company”) (NASDAQ: CMBM). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or…
NEW YORK, June 15, 2024 /PRNewswire/ — Pomerantz LLP announces that a class action lawsuit has been filed against Humana Inc. (“Humana” or the “Company”) (NYSE: HUM). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW),…
NEW YORK, June 15, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Lasertec Corporation (“Lasertec” or the “Company”) (OTC: LSRCF). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The…
NEW YORK, June 15, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Graphjet Technology (“Graphjet” or the “Company”) (NASDAQ: GTI). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The…
NEW YORK, June 15, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Cibus, Inc. (“Cibus” or the “Company”) (NASDAQ: CBUS). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation…
NEW YORK, June 15, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of BridgeBio Pharma, Inc. (“BridgeBio” or the “Company”) (NASDAQ: BBIO). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The…
NEW YORK, June 15, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Sprinklr, Inc. (“Sprinklr” or the “Company”) (NYSE: CXM). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation…
NEW YORK, June 15, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Biomea Fusion, Inc. (“Biomea” or the “Company”) (NASDAQ: BMEA). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The…